BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 18212541)

  • 1. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL; Veikkola T; Valtola R; Weiss SW
    Mod Pathol; 2000 Feb; 13(2):180-5. PubMed ID: 10697276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retiform hemangioendothelioma: presentation of a case expressing D2-40.
    Emberger M; Laimer M; Steiner H; Zelger B
    J Cutan Pathol; 2009 Sep; 36(9):987-90. PubMed ID: 19674202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
    Fukunaga M
    Histopathology; 2005 Apr; 46(4):396-402. PubMed ID: 15810951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
    Castro EC; Galambos C
    Pediatr Dev Pathol; 2009; 12(3):187-94. PubMed ID: 18937526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unclassified epithelioid vascular tumor with hemangioendotheliomatous features and lymphatic differentiation.
    Oshiro Y; Kohashi K; Oda Y; Tsuneyoshi M; Shono Y
    Pathol Int; 2009 Jun; 59(6):410-4. PubMed ID: 19490473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
    Galambos C; Nodit L
    Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor receptor 3 in blood and lymphatic vessels of lung adenocarcinoma.
    Niki T; Iba S; Yamada T; Matsuno Y; Enholm B; Hirohashi S
    J Pathol; 2001 Apr; 193(4):450-7. PubMed ID: 11276003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desmoplakin and Plakoglobin--specific markers of lymphatic vessels in the skin?
    Fedele C; Berens D; Rautenfeld V; Pabst R
    Anat Histol Embryol; 2004 Jun; 33(3):168-71. PubMed ID: 15144286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ; Bailey D; Marks A
    Mod Pathol; 2002 Apr; 15(4):434-40. PubMed ID: 11950918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemangioendothelioma.
    Requena L; Kutzner H
    Semin Diagn Pathol; 2013 Feb; 30(1):29-44. PubMed ID: 23327728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
    Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
    Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors.
    Lymboussaki A; Partanen TA; Olofsson B; Thomas-Crusells J; Fletcher CD; de Waal RM; Kaipainen A; Alitalo K
    Am J Pathol; 1998 Aug; 153(2):395-403. PubMed ID: 9708800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
    Pusztaszeri MP; Seelentag W; Bosman FT
    J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
    Clarijs R; Schalkwijk L; Hofmann UB; Ruiter DJ; de Waal RM
    Cancer Res; 2002 Dec; 62(23):7059-65. PubMed ID: 12460927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can lymphangiosarcoma be resurrected? A clinicopathological and immunohistochemical study of lymphatic differentiation in 49 angiosarcomas.
    Mankey CC; McHugh JB; Thomas DG; Lucas DR
    Histopathology; 2010 Feb; 56(3):364-71. PubMed ID: 20459536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Composite hemangioendothelioma: report of 5 cases including one with associated Maffucci syndrome.
    Fukunaga M; Suzuki K; Saegusa N; Folpe AL
    Am J Surg Pathol; 2007 Oct; 31(10):1567-72. PubMed ID: 17895759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of D2-40 immunohistochemistry for differentiation between kaposiform hemangioendothelioma and tufted angioma.
    Arai E; Kuramochi A; Tsuchida T; Tsuneyoshi M; Kage M; Fukunaga M; Ito T; Tada T; Izumi M; Shimizu K; Hirose T; Shimizu M
    J Cutan Pathol; 2006 Jul; 33(7):492-7. PubMed ID: 16872472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA; Alitalo K; Miettinen M
    Cancer; 1999 Dec; 86(11):2406-12. PubMed ID: 10590384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased human tissues.
    Wilting J; Papoutsi M; Christ B; Nicolaides KH; von Kaisenberg CS; Borges J; Stark GB; Alitalo K; Tomarev SI; Niemeyer C; Rössler J
    FASEB J; 2002 Aug; 16(10):1271-3. PubMed ID: 12060670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.